MOF Biomarker Preservation: Advanced Molecular Stability Tech

Publication ID: 24-11856945_0008_PTD

Published: October 26, 2025

Category:Synergistic Combinations

Legal Citation

pr1or.art Inc., “MOF Biomarker Preservation: Advanced Molecular Stability Tech,” Published Technical Disclosure No. 24-11856945_0008_PTD, Published October 26, 2025, available at https://archive.pr1or.art/24-11856945_0008_PTD

This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,856,945.

Background and Problem Solved

The original patent addressed the poor stability of molecular biomarkers in biological samples during the pre-analytical stage. However, it did not provide solutions for real-time monitoring, decentralized collection and analysis, or personalized medicine applications. This new invention solves these problems by combining MOF encapsulants with cutting-edge technologies.

Novelty and Inventive Step

The new claims introduce the innovative combination of MOF encapsulants with distinct technologies, providing a synergistic effect that enhances the preservation, monitoring, and analysis of biological samples. This integration is non-obvious and goes beyond the original patent's scope.

Alternative Embodiments and Variations

Alternative embodiments may include the use of different MOF types, varying sensor configurations, or alternative AI algorithms. Variations may also involve the integration of additional technologies, such as robotics or augmented reality, to further enhance the systems and methods.

Potential Commercial Applications and Market

This invention has significant commercial potential in the biomedical research, clinical diagnosis, and personalized medicine industries. It can enable the development of new diagnostic tools, improve the quality of biospecimens, and facilitate more effective treatment strategies. The market for these systems and methods is substantial, with potential applications in hospitals, research institutions, and pharmaceutical companies.

CPC Classifications

Section	Class	Group
A	A01	A01N1/0231
G	G01	G01N1/4044

Section 103 Obviousness Analysis (PHOSITA)

▼

Field of Art

Biomedical sample preservation and analysis technologies, focusing on molecular stabilization techniques and advanced preservation methods involving metal-organic frameworks (MOFs)

Person of Ordinary Skill (PHOSITA) Profile

A biomedical engineer or biotechnologist with expertise in molecular preservation techniques, familiar with MOF encapsulation technologies, sensor integration, and advanced diagnostic platforms

Obviousness Rationale

A PHOSITA would recognize that integrating blockchain, IoT, and AI technologies with MOF-based sample preservation represents a predictable extension of existing preservation techniques. The source patent's foundational MOF encapsulation method provides a clear technical framework for implementing additional tracking and monitoring technologies. These variations represent standard technological convergence in biomedical sample management.

Obvious Combinations & Variations

Source Patent Element

Metal-organic framework (MOF) encapsulation method for biological sample preservation

PTD Variation

Blockchain-based tracking system integrated with MOF encapsulant

Obviousness Reasoning

Combining tracking technologies with preservation methods is a known technique in biomedical sample management, representing a predictable solution to sample authentication and integrity monitoring

Source Patent Element

MOF preservation of protein biomarkers in biofluids

PTD Variation

AI-powered diagnostic platform for analyzing biomarker data

Obviousness Reasoning

Applying machine learning algorithms to biomarker analysis is a standard approach in personalized medicine, representing an obvious technological progression

Source Patent Element

MOF encapsulation for molecular stabilization

PTD Variation

IoT-enabled sensor integration for real-time sample condition monitoring

Obviousness Reasoning

Implementing sensor technologies for environmental monitoring of preserved samples is a predictable enhancement using known instrumentation techniques

Source Patent Element

MOF preservation of protein-based materials

PTD Variation

Microfluidic device for controlled therapeutic release

Obviousness Reasoning

Combining preservation technologies with controlled release mechanisms represents a standard design approach in biomedical engineering with finite, predictable implementation strategies

35 U.S.C. § 103 Summary: Based on US Patent 11856945's foundational MOF encapsulation method, the present disclosure demonstrates that a person having ordinary skill in the art would find the integration of blockchain, IoT, AI, and microfluidic technologies with MOF-based sample preservation to be an obvious technological progression, thereby rendering potential derivative claims obvious and anticipatable as prior art.

Original Patent Information

Patent Number	US 11,856,945
Title	Methods and systems for preparing and preserving a biological sample
Assignee(s)	Washington University